| Financial Year |
March 31 2023 |
| Monetary Funds |
175,312,019.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
105,115,507.33 |
| Accounts Receivable |
902,751,838.68 |
| Advances to Suppliers |
49,871,376.51 |
| Other Receivables |
20,087,866.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
321,319,045.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,539,265.94 |
| Total Current Assets |
1,774,933,606.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,097,508.80 |
| Investment Properties |
-- |
| Fixed Assetes |
427,046,207.86 |
| Under-construction Projects |
4,769,317.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,383,874.65 |
| R&D expenses |
-- |
| Goodwill |
856,336.75 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
84,394,282.92 |
| Other Non-Current Assets |
65,576,841.76 |
| Sub-Total of Non-Current Assets |
651,476,206.90 |
| Total Assets |
2,426,409,813.04 |
| Short-Term Loans |
294,058,375.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
240,688,846.00 |
| Accounts Payable |
384,800,666.52 |
| Accounts Received In Advance |
71,622.07 |
| Employee Compensation Payable |
6,578,590.71 |
| Taxes Payable |
14,606,969.04 |
| Interest Payable |
1,099,891.99 |
| Dividend Payable |
-- |
| Other payables |
172,744,544.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
204,500,000.00 |
| Other Current Liabilities |
60,053,484.29 |
| Sub-Total of Current Liabilities |
1,427,375,764.87 |
| Long-term Loans |
110,520,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,390,945.73 |
| Other Non-Current Liabilities |
50,511,642.98 |
| Sub-Total of Non-Current Liabilities |
163,422,588.71 |
| Total Liabilities |
1,590,798,353.58 |
| Paid-In Capital(Or Share Stock) |
383,340,672.00 |
| Capital Surplus |
80,867,229.51 |
| Surplus Reserve |
152,844,951.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
198,489,946.38 |
| Minority Stockholder's Interest |
18,774,552.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
816,836,906.75 |
| Owner's Equity（Stockholder's Equity） |
835,611,459.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,426,409,813.04 |
